Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Letter to the Shareholders of Patriot Scientific Corporation from President/CEO

I understand your frustration with the idea of 100M more authorized shares. But here's what I think is basically going on:

Revenues from the MMP, with the re-exams going on, are now more a "someday, maybe/probably" thing. Licensing has come to a near stop for IMO one very logical reason - if they wait for revalidation of just one patent, they can demand much more from future licensees. But, as RG has warned, the process is slow and relatively unpredictable re: outcome (i.e., a failure with the PTO will probably prompt our next action to reverse the decision, and that process could go on for years). So what to do?

I think that, with the big unknowns currently surrounding the MMP, RG&Co have put their "pretend hats" on. Pretend the MMP isn't there. Now, how to we grow this company with the assets on hand? But the marketable assets (excluding the MMP) are limited. So develop/gain approval of more marketable assets - more shares. Use those assets to acquire and foster some revenue generation engines. Really, with an eye to grow, it's about the only thing they can do (short of another Swartz-type deal).

Meanwhile, if we are fortunate enough to see something positive from the PTO, there is no need to change the direction of growth. The same actions being taken can continue, but probably with hard cash to use as the acquisition asset rather than the newly authorized shares.

What I'm really hoping for is a positive outcome from the PTO before the shareholders meeting. With that, I suspect the request for more shares could be set aside. I may be again suffering delusions with the thought that the PTO will act that fast, but that's my hope.

But even if the PTO comes through later, any used authorized shares could be retired.

JMHO,

SGE

Share
New Message
Please login to post a reply